AMPH earnings: a positive outcome, +12.6%

On March 11, 2022, Amphastar Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.6% in the window around the event. It had already run +14.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.